Hiromu Ito

12.2k total citations · 2 hit papers
272 papers, 8.3k citations indexed

About

Hiromu Ito is a scholar working on Surgery, Rheumatology and Molecular Biology. According to data from OpenAlex, Hiromu Ito has authored 272 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 129 papers in Surgery, 120 papers in Rheumatology and 28 papers in Molecular Biology. Recurrent topics in Hiromu Ito's work include Rheumatoid Arthritis Research and Therapies (73 papers), Total Knee Arthroplasty Outcomes (71 papers) and Orthopaedic implants and arthroplasty (59 papers). Hiromu Ito is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (73 papers), Total Knee Arthroplasty Outcomes (71 papers) and Orthopaedic implants and arthroplasty (59 papers). Hiromu Ito collaborates with scholars based in Japan, United States and United Kingdom. Hiromu Ito's co-authors include Hiroyuki Yoshitomi, Shuichi Matsuda, Takashi Nakamura, Moritoshi Furu, Kohei Nishitani, Motomu Hashimoto, Masahiro Ishikawa, Koichi Murata, Shinichi Kuriyama and Shinichiro Nakamura and has published in prestigious journals such as Science, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Hiromu Ito

260 papers receiving 8.2k citations

Hit Papers

Preferential recruitment of CCR6-expressing Th17 cells to... 2007 2026 2013 2019 2007 2018 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiromu Ito Japan 48 2.7k 2.2k 1.7k 1.5k 955 272 8.3k
Ji Hyeon Ju South Korea 44 884 0.3× 2.7k 1.2× 2.0k 1.2× 1.5k 1.0× 505 0.5× 245 6.7k
Tetsuya Tomita Japan 40 1.9k 0.7× 1.5k 0.7× 1.2k 0.7× 934 0.6× 551 0.6× 221 5.4k
Michael Heberer Switzerland 47 2.1k 0.8× 1.5k 0.7× 1.7k 1.0× 1.8k 1.2× 2.1k 2.2× 126 7.6k
Andrea Facchini Italy 48 1.4k 0.5× 3.0k 1.3× 1.6k 0.9× 887 0.6× 465 0.5× 144 6.7k
Dianna M. Milewicz United States 73 3.9k 1.4× 1.0k 0.5× 2.9k 1.7× 889 0.6× 433 0.5× 273 19.6k
Hagen Schmal Germany 45 3.5k 1.3× 1.7k 0.8× 766 0.4× 1.2k 0.8× 807 0.8× 255 6.7k
Lawrence Rosenberg Canada 57 3.4k 1.3× 2.5k 1.1× 2.9k 1.7× 537 0.4× 720 0.8× 171 9.6k
Finn P. Reinholt Sweden 45 2.1k 0.8× 1.8k 0.8× 1.6k 1.0× 526 0.4× 384 0.4× 199 6.8k
Lingyun Sun China 55 1.5k 0.5× 1.9k 0.8× 3.0k 1.7× 2.9k 2.0× 691 0.7× 243 10.3k
Joachim Grifka Germany 44 7.0k 2.6× 1.9k 0.8× 2.2k 1.3× 384 0.3× 956 1.0× 512 12.6k

Countries citing papers authored by Hiromu Ito

Since Specialization
Citations

This map shows the geographic impact of Hiromu Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiromu Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiromu Ito more than expected).

Fields of papers citing papers by Hiromu Ito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiromu Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiromu Ito. The network helps show where Hiromu Ito may publish in the future.

Co-authorship network of co-authors of Hiromu Ito

This figure shows the co-authorship network connecting the top 25 collaborators of Hiromu Ito. A scholar is included among the top collaborators of Hiromu Ito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiromu Ito. Hiromu Ito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Iwasaki, Takashi, Ryu Watanabe, Hiromu Ito, et al.. (2023). POS0241 MONOCYTE-DERIVED TRANSCRIPTOMES EXPLAIN THE INEFFECTIVENESS OF ABATACEPT IN RHEUMATOID ARTHRITIS. Annals of the Rheumatic Diseases. 82. 353–354. 1 indexed citations
3.
Doi, Hiroshi, Ryu Watanabe, Koichi Murata, et al.. (2023). Factors associated with osteoporosis and fractures in patients with systemic lupus erythematosus: Kyoto Lupus Cohort. Modern Rheumatology. 34(1). 113–121. 4 indexed citations
5.
Ito, Isao, Masao Tanaka, Koichi Murata, et al.. (2023). Impact of methotrexate on humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis. Clinical and Experimental Medicine. 23(8). 4707–4720. 2 indexed citations
6.
7.
Ito, Hiromu, et al.. (2023). Evaluation of muscle strength recovery following superior capsular reconstruction using a tensor fascia lata graft: a comparison with the unaffected side. Journal of Shoulder and Elbow Surgery. 32(8). 1681–1688. 5 indexed citations
8.
Ishikawa, Yuki, Takeshi Iwasaki, Ryosuke Hiwa, et al.. (2022). Genetic architecture underlying IgG-RF production is distinct from that of IgM-RF. Lara D. Veeken. 62(5). 2015–2020. 1 indexed citations
9.
Hashimoto, Motomu, Ryuji Uozumi, Mie Torii, et al.. (2021). Factors associated with anxiety and depression in rheumatoid arthritis patients: a cross-sectional study. Advances in Rheumatology. 61(1). 12 indexed citations
10.
Shirakashi, Mirei, Mikako Maruya, Keiji Hirota, et al.. (2021). Effect of Impaired T Cell Receptor Signaling on the Gut Microbiota in a Mouse Model of Systemic Autoimmunity. Arthritis & Rheumatology. 74(4). 641–653. 30 indexed citations
11.
Kojima, Masayo, Shintaro Hirata, Hiromu Ito, et al.. (2021). Patients’ perspectives of rheumatoid arthritis treatment: a questionnaire survey for the 2020 update of the Japan college of rheumatology clinical practice guidelines. Modern Rheumatology. 32(2). 307–312. 5 indexed citations
12.
Watanabe, Ryu, Motomu Hashimoto, Koichi Murata, et al.. (2021). Neutrophil count reduction 1 month after initiating tocilizumab can predict clinical remission within 1 year in rheumatoid arthritis patients. Rheumatology International. 42(11). 1983–1991. 5 indexed citations
13.
Taniguchi, Masashi, Tome Ikezoe, Mitsuhiro Masaki, et al.. (2021). Coexistence of Low Back Pain and Lumbar Kyphosis and the Association With Increased Functional Disability in Knee Osteoarthritis: Results From a Population‐Based Cohort. Arthritis Care & Research. 74(10). 1667–1675. 2 indexed citations
14.
15.
Ito, Hiromu, Koichi Murata, Motomu Hashimoto, et al.. (2019). Distinct biomarkers for different bones in osteoporosis with rheumatoid arthritis. Arthritis Research & Therapy. 21(1). 174–174. 24 indexed citations
16.
Ito, Hiromu, Shigeyoshi Tsuji, Yuichi Mochida, et al.. (2019). Does Abatacept Increase Postoperative Adverse Events in Rheumatoid Arthritis Compared with Conventional Synthetic Disease-modifying Drugs?. The Journal of Rheumatology. 47(4). 502–509. 9 indexed citations
17.
Ito, Hiromu, Shinjiro Tominari, Yasuharu Tabara, et al.. (2019). Low back pain precedes the development of new knee pain in the elderly population; a novel predictive score from a longitudinal cohort study. Arthritis Research & Therapy. 21(1). 98–98. 17 indexed citations
18.
Hashimoto, Motomu, Hiroko Yamamoto, Masao Tanaka, et al.. (2018). Non-obese visceral adiposity is associated with the risk of atherosclerosis in Japanese patients with rheumatoid arthritis: a cross-sectional study. Rheumatology International. 38(9). 1679–1689. 15 indexed citations
19.
Nakagawa, Shunsaku, Motomu Hashimoto, Hiromu Ito, et al.. (2018). Effect of medication adherence on disease activity among Japanese patients with rheumatoid arthritis. PLoS ONE. 13(11). e0206943–e0206943. 16 indexed citations
20.
Murata, Koichi, Hiromu Ito, Motomu Hashimoto, et al.. (2018). Elderly onset of early rheumatoid arthritis is a risk factor for bone erosions, refractory to treatment: KURAMA cohort. International Journal of Rheumatic Diseases. 22(6). 1084–1093. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026